Share “News Summary: Merck suspends Tredaptive sales”

News Summary: Merck suspends Tredaptive sales

Published on NewsOK Modified: January 11, 2013 at 10:43 am •  Published: January 11, 2013

SUSPECT MEDICINE: Merck & Co. is suspending sales of the cholesterol drug Tredaptive after initial results from a study showed that it wasn't effective and could raise the risk of some serious side effects.

WHO'S AFFECTED: The tablets aren't approved in the United States, but they are sold in about 40 countries, including in Europe.

WHAT WENT WRONG: Merck says the side effects were not fatal and fell into several broad categories: blood and lymphatic, gastrointestinal, infections, metabolism, musculoskeletal, respiratory and skin.


  1. 1
    This map shows the biggest music festival in Oklahoma, other states
  2. 2
    Bristol Palin Slams Washington State Initiative to Give Free Birth Control to Minors
  3. 3
    Oregon pot stores sell more than $11 million in first 5 days
  4. 4
    Sigourney Weaver turns 66: Then and now
  5. 5
    Not Sucking in Their Seventies: Rock Lifers Go the Distance
+ show more


× Trending health Article